Burkly Linda — SEC Form 4 filings
SEC reporting owner CIK 1985604. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-05 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 10 filings — 29,164 shares, $105,501 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 11,886 shares @ $5.42 ($64,370) in Editas Medicine, Inc., filed 2024-07-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | 13 | — | 10 legs · 29,164 sh · $105,501 | 6 |
Form 4 filings — Burkly Linda
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 709 @ $3.04 | EDGAR |
| 2026-07-29 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 4,928 @ $2.67 | EDGAR |
| 2026-06-05 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 731 @ $2.70 | EDGAR |
| 2026-03-16 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 292,856 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 749 @ $2.02 | EDGAR |
| 2025-12-04 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 713 @ $2.15 | EDGAR |
| 2025-09-04 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 710 @ $2.60 | EDGAR |
| 2025-08-04 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 5,121 @ $2.49 | EDGAR |
| 2025-06-04 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 726 @ $1.72 | EDGAR |
| 2025-03-27 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 275,100 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 2,891 @ $1.71 | EDGAR |
| 2024-07-26 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 11,886 @ $5.42 | EDGAR |
| 2024-03-05 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 24,800 @ $0 · Grant/award (A): 15,055 @ $0 · Grant/award (A): 74,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1985604 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →